SQUAMOUS CELL NON SMALL CELL LUNG CANCER
Clinical trials for SQUAMOUS CELL NON SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new SQUAMOUS CELL NON SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for SQUAMOUS CELL NON SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise for Hard-to-Treat cancers
Disease control Recruiting nowThis study is testing a new experimental drug called GI-101, given alone or with pembrolizumab or lenvatinib, in people with advanced or metastatic solid tumors (cancers that have spread). The goal is to see if the drug is safe and can shrink or control tumors. About 317 adults w…
Matched conditions: SQUAMOUS CELL NON SMALL CELL LUNG CANCER
Phase: PHASE1, PHASE2 • Sponsor: GI Innovation, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New Antibody-Drug conjugate ZW251 enters first human trials for Hard-to-Treat cancers
Disease control Recruiting nowThis early-stage trial is testing a new drug called ZW251 in about 100 people with advanced solid tumors, including liver cancer (hepatocellular carcinoma), a type of lung cancer (squamous cell non-small cell lung cancer), and germ cell tumors. ZW251 is an antibody-drug conjugate…
Matched conditions: SQUAMOUS CELL NON SMALL CELL LUNG CANCER
Phase: PHASE1 • Sponsor: Zymeworks BC Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New cancer drug ABBV-324 enters first human trials
Disease control Recruiting nowThis early-stage trial tests an investigational drug called ABBV-324 in about 232 adults with liver cancer (hepatocellular carcinoma) or a type of lung cancer (squamous-cell non-small cell lung cancer). Some participants receive ABBV-324 alone, while others get a standard drug ca…
Matched conditions: SQUAMOUS CELL NON SMALL CELL LUNG CANCER
Phase: PHASE1 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC